1.30
前日終値:
$1.01
開ける:
$1.05
24時間の取引高:
13.98M
Relative Volume:
28.30
時価総額:
$14.99M
収益:
$996.00K
当期純損益:
$-6.09M
株価収益率:
-2.4528
EPS:
-0.53
ネットキャッシュフロー:
$-9.76M
1週間 パフォーマンス:
+26.21%
1か月 パフォーマンス:
+23.81%
6か月 パフォーマンス:
-22.85%
1年 パフォーマンス:
-42.48%
Therapeuticsmd Inc Stock (TXMD) Company Profile
名前
Therapeuticsmd Inc
セクター
電話
561-961-1900
住所
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
TXMD を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
TXMD
Therapeuticsmd Inc
|
1.30 | 14.99M | 996.00K | -6.09M | -9.76M | -0.53 |
![]()
ZTS
Zoetis Inc
|
160.46 | 71.85B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
HLN
Haleon Plc Adr
|
10.08 | 45.58B | 14.26B | 1.55B | 0 | 0.3383 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.58B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.74 | 19.18B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
ITCI
Intra Cellular Therapies Inc
|
128.60 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2020-08-07 | ダウングレード | Jefferies | Hold → Underperform |
2020-05-19 | ダウングレード | JP Morgan | Overweight → Neutral |
2019-12-02 | 開始されました | Guggenheim | Buy |
2019-10-17 | 開始されました | H.C. Wainwright | Buy |
2019-04-30 | 再開されました | Noble Capital Markets | Outperform |
2018-06-15 | 開始されました | JP Morgan | Overweight |
2017-09-08 | 開始されました | Morgan Stanley | Equal-Weight |
2017-07-11 | アップグレード | Oppenheimer | Perform → Outperform |
2017-05-09 | ダウングレード | Oppenheimer | Outperform → Perform |
2016-11-22 | 再開されました | Jefferies | Buy |
2016-11-22 | 開始されました | Oppenheimer | Outperform |
2016-11-07 | 再開されました | Guggenheim | Buy |
2016-04-04 | 開始されました | Goldman | Buy |
2015-12-08 | 繰り返されました | Jefferies | Buy |
2015-12-08 | 繰り返されました | Stifel | Buy |
2015-09-21 | 繰り返されました | Jefferies | Buy |
2015-06-09 | 開始されました | Guggenheim | Buy |
2014-07-08 | 開始されました | FBR Capital | Outperform |
2014-04-17 | 繰り返されました | Noble Financial | Buy |
2014-01-28 | 繰り返されました | Noble Financial | Buy |
すべてを表示
Therapeuticsmd Inc (TXMD) 最新ニュース
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
How does TXMD’s price to cash per share ratio compare in the market? - US Post News
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD) - Defense World
TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch
TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
TherapeuticsMD (NASDAQ:TXMD) Coverage Initiated at StockNews.com - Defense World
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch
3 Promising US Penny Stocks With Over $9M Market Cap - Simply Wall St
StockNews.com Initiates Coverage on TherapeuticsMD (NASDAQ:TXMD) - Defense World
TXMD stock touches 52-week low at $1.04 amid market challenges - Investing.com Nigeria
TXMD stock touches 52-week low at $1.04 amid market challenges By Investing.com - Investing.com South Africa
TherapeuticsMD Inc. stock remains steady Friday, still outperforms market - MarketWatch
TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com - Defense World
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
TXMD stock touches 52-week low at $1.13 amid market challenges By Investing.com - Investing.com South Africa
TXMD stock touches 52-week low at $1.13 amid market challenges - Investing.com India
TherapeuticsMD Inc. stock remains steady Thursday, still outperforms market - MarketWatch
Therapeuticsmd Inc (TXMD) 財務データ
収益
当期純利益
現金流量
EPS
Therapeuticsmd Inc (TXMD) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Naughton Gail K | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
8,500 |
Thompson Tommy G | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
14,454 |
Walker Marlan D | Chief Executive Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
8,281 |
0 |
70,846 |
Collins Cooper C. | Director |
Aug 22 '24 |
Buy |
1.73 |
4,094 |
7,099 |
52,016 |
Collins Cooper C. | Director |
Aug 21 '24 |
Buy |
1.70 |
1,200 |
2,039 |
47,922 |
大文字化:
|
ボリューム (24 時間):